Positron emission tomography with computed tomography imaging (PET/CT) for the radiotherapy planning definition of the biological target volume: PART 2.
Imaging
PET/CT
Radiotherapy
Target volume
Journal
Critical reviews in oncology/hematology
ISSN: 1879-0461
Titre abrégé: Crit Rev Oncol Hematol
Pays: Netherlands
ID NLM: 8916049
Informations de publication
Date de publication:
Jul 2019
Jul 2019
Historique:
received:
05
02
2019
revised:
14
03
2019
accepted:
14
03
2019
pubmed:
4
4
2019
medline:
10
9
2019
entrez:
4
4
2019
Statut:
ppublish
Résumé
Positron Emission Tomography with Computed Tomography (PET/CT) has been proven to be useful in the definition of Radiotherapy (RT) target volume. In this regard, the present expert review summarizes existing data for pancreas, prostate, gynecological and rectum/anal cancer. A comprehensive search of published original article was made, based on SCOPUS and PubMed database, selecting the paper that evaluated the role of PET/CT in the definition of RT volume. FDG-PET has an important and promising role for pancreatic cancer. Choline PET/CT could be useful for identifying high-risk volumes for prostate cancer; while PSMA PET/CT is still under evaluation. FDG PET/CT in gynecological cancers has been shown to impact external-beam RT planning. The role of FDG-PET for Gross Tumor volume identification is crucial, representing a useful and powerful tool for anal and rectal cancer. Taken together, molecular and functional imaging approaches offer a major step to individualize radiotherapeutic approach.
Identifiants
pubmed: 30940428
pii: S1040-8428(19)30060-5
doi: 10.1016/j.critrevonc.2019.03.008
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
117-124Informations de copyright
Copyright © 2019 Elsevier B.V. All rights reserved.